A   B   C   D   E   F   G   H   I   J    K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z


This is a listing of all of the drugs covered by MassHealth. Please select a letter to see drugs listed by that letter, or enter the name of the drug you wish to search for.


Refine Search Table

      (Please specify search value)

 
MassHealth Drug List table
Drug - Brand Name (Generic Name) Class
Jadenu (deferasirox 90 mg, 180 mg, 360 mg)drugId:4942 ANTIDOTES
Jakafi (ruxolitinib)drugId:2418 - PA CHEMOTHERAPY
Jalyn (dutasteride / tamsulosin)drugId:1960 - PA BENIGN PROSTATIC HYPERPLASIA AGENTS
Janumet (sitagliptin / metformin)drugId:1859 - PA DIABETIC AGENTS
Janumet XR (sitagliptin / metformin extended-release)drugId:2485 - PA DIABETIC AGENTS
Januvia (sitagliptin)drugId:1858 - PA DIABETIC AGENTS
japanese encephalitis vaccinedrugId:2044 BIOLOGICAL
Jardiance (empagliflozin)drugId:4627 - PA DIABETIC AGENTS
Jentadueto (linagliptin / metformin)drugId:2486 - PA DIABETIC AGENTS
Jentadueto XR (linagliptin / metformin extended-release)drugId:5724 - PA DIABETIC AGENTS
Jetrea (ocriplasmin) ^ OPHTHALMIC PREPARATIONS
Jevtana (cabazitaxel)drugId:1961 - PA CHEMOTHERAPY
Jublia (efinaconazole)drugId:4628 - PA ANTIBIOTICS
Juluca (dolutegravir / rilpivirine)drugId:6781 - PA ANTIVIRALS
Juxtapid (lomitapide)drugId:2727 - PA LIPID LOWERING AGENTS
Jynarque (tolvaptan-Jynarque)drugId:6801 - PA VASOPRESSIN ANTAGONISTS

MassHealth Drug List Footnotes
PA Prior authorization is required. The prescriber must obtain prior authorization for the drug in order for the pharmacy to receive payment. Note: Prior authorization applies to both the brand-name and the FDA "A"-rated generic equivalent of listed product.
 
# This designates a brand-name drug with FDA “A”-rated generic equivalents. Prior authorization is required for the brand, unless a particular form of that drug (for example, tablet, capsule, or liquid) does not have an FDA “A”-rated generic equivalent.
 
BP Brand Preferred over generic equivalents. In general, MassHealth requires a trial of the preferred drug or clinical rationale for prescribing the non-preferred drug generic equivalent.
 
PD Preferred Drug. In general, MassHealth requires a trial of the preferred drug or clinical rationale for prescribing a non-preferred drug within a therapeutic class.
 
* The generic OTC and, if any, generic prescription versions of the drug are payable under MassHealth without prior authorization.
 
o Prior-authorization status depends on the drug's formulation.
 
^ This drug is available through the health care professional who administers the drug. MassHealth does not pay for this drug to be dispensed through a retail pharmacy.
 
1 Product may be available through the Massachusetts Department of Public Health (DPH). Please check with DPH for availability. MassHealth does not pay for immunizing biologicals (i.e., vaccines) and tubercular (TB) drugs that are available free of charge through local boards of public health or through the Massachusetts Department of Public Health without prior authorization (130 CMR 406.413(C)). In cases where free vaccines are available to providers for specific populations (e.g. children, high risk, etc.), MassHealth will reimburse the provider only for individuals not eligible for the free vaccines. Notwithstanding the above, MassHealth will pay pharmacies for seasonal flu vaccine serum without prior authorization, if the vaccine is administered in the pharmacy.
 
2 Prior authorization status is gender specific.
 

Note: Any drug that does not appear on the List requires prior authorization.


Back to Top | Previous | Next
Last updated 10/22/18